Schedule 13G ownership disclosure

PTC Therapeutics Inc

Security class unavailable · CUSIP: 69366J200

Event date: 2017-03-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,051,657
Percent of class
3.0400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902219-17-000519
Form type
SC 13G/A
Filer
PTC THERAPEUTICS, INC.
CIK
CIK 1070081
Filed
Apr 10, 2017
Reporting period
Mar 31, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub